Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial

Controlled Trial ◽

Faculty Opinions recommendation of Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13436981.14828060 ◽

2012 ◽

Author(s):

Phillip Lieberman ◽

Jay Lieberman

Keyword(s):

Controlled Trial ◽

Faculty Opinions recommendation of Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13436981.14866055 ◽

2012 ◽

Author(s):

Julie Wang

Keyword(s):

Controlled Trial ◽

How to (tr)eat?: A double-blind randomized controlled trial investigating broad-spectrum micronutrients in highly impulsive children and adolescents

10.1055/s-0039-1679186 ◽

2019 ◽

Author(s):

K Mechler ◽

T Banaschewski ◽

R Berg ◽

A Dietrich ◽

P Hoekstra ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Broad Spectrum ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2018.09.047 ◽

2018 ◽

Vol 121 (5) ◽

pp. S15

Author(s):

I. Hirano ◽

M. Collins ◽

Y. Assouline-Dayan ◽

L. Evans ◽

S. Gupta ◽

...

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 13

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial

European Journal of Pediatrics ◽

10.1007/s00431-019-03384-x ◽

2019 ◽

Vol 178 (7) ◽

pp. 1013-1021 ◽

Cited By ~ 3

Author(s):

Franz Schaefer ◽

Djalila Mekahli ◽

Francesco Emma ◽

Rodney D. Gilbert ◽

Detlef Bockenhauer ◽

...

Keyword(s):

Kidney Disease ◽

Autosomal Dominant Polycystic Kidney

Polycystic Kidney Disease ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2019.0176 ◽

2020 ◽

Vol 30 (6) ◽

pp. 355-365

Author(s):

Robert L. Findling ◽

Emily McCusker ◽

Jeffrey R. Strawn

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Open Label ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/chi.0b013e31819c55ec ◽

2009 ◽

Vol 48 (5) ◽

pp. 519-532 ◽

Cited By ~ 71

Author(s):

Karen Dineen Wagner ◽

Laura Redden ◽

Robert A. Kowatch ◽

Timothy E. Wilens ◽

Scott Segal ◽

...

Keyword(s):

Bipolar Disorder ◽

Extended Release ◽

Controlled Trial ◽

Paroxetine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000138356.29099.f1 ◽

2004 ◽

Vol 43 (11) ◽

pp. 1387-1396 ◽

Cited By ~ 142

Author(s):

DANIEL A. GELLER ◽

KAREN DINEEN WAGNER ◽

GRAHAM EMSLIE ◽

TANYA MURPHY ◽

DAVID J. CARPENTER ◽

...

Keyword(s):

Obsessive Compulsive Disorder ◽

Controlled Trial ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Compulsive Disorder ◽

Paroxetine Treatment

Clinical Features at Baseline are Not Clearly Associated with Symptomatic Placebo Response in Adolescents and Adults with Eosinophilic Esophagitis During a Placebo Run-in Period of a Double-Blind, Randomized, Controlled Trial of Budesonide Oral Suspension

Gastroenterology ◽

10.1016/s0016-5085(17)32941-4 ◽

2017 ◽

Vol 152 (5) ◽

pp. S854 ◽

Cited By ~ 2

Author(s):

Ikuo Hirano ◽

James Williams ◽

Margaret H. Collins ◽

Evan S. Dellon ◽

Sharif Uddin ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Clinical Features ◽

Controlled Trial ◽

Placebo Response ◽

Oral Suspension ◽

Double Blind ◽

Randomized Controlled ◽

Adolescents And Adults

Reslizumab in Children and Adolescents With Eosinophilic Esophagitis: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(11)60554-4 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-136 ◽

Cited By ~ 1

Author(s):

Jonathan M. Spergel ◽

Marc E. Rothenberg ◽

Margaret H. Collins ◽

Glenn Furuta ◽

Jonathan E. Markowitz ◽

...

Keyword(s):

Controlled Study ◽